# DNA X (SONM) — Earnings

SONM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sonm/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$4.83 |
| EPS estimate | $5.40 |
| EPS surprise | −189.44% |
| Revenue surprise | −52.79% |
| Revenue | $16.2M |
| Revenue estimate | $34.3M |
| Reported | Oct 31, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1178697/000149315225020310/form10-q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Oct 31, 2025 | $5.40 | −$4.83 | -189.44% | $34.3M | $16.2M |
| Q2 2025 | Aug 8, 2025 | $0.72 | −$14.22 | -2075.00% | $29.2M | $11.2M |
| Q1 2025 | May 12, 2025 | −$2.34 | $1.44 | 161.54% | $25.4M | $16.7M |
| Q4 2024 | Mar 31, 2025 | −$7.20 | −$81.00 | -1025.00% | $19.6M | $15.0M |
| Q3 2024 | Nov 13, 2024 | −$11.88 | −$9.36 | 21.21% | $14.8M | $15.0M |
| Q2 2024 | Aug 9, 2024 | −$9.72 | −$25.38 | -161.11% | $10.9M | $11.5M |
| Q1 2024 | May 14, 2024 | −$5.40 | −$12.60 | -133.33% | $18.0M | $16.8M |
| Q4 2023 | Mar 27, 2024 | $1.80 | −$5.40 | -400.00% | $27.6M | $13.4M |
| Q3 2023 | Nov 14, 2023 | $0.00 | $1.80 | 0.00% | — | $27.6M |
| Q3 2022 | Nov 14, 2022 | −$36.00 | −$7.20 | 80.00% | $25.5M | $20.5M |
| Q1 2022 | May 10, 2022 | −$90.00 | −$68.40 | 24.00% | $20.5M | $13.3M |
| Q3 2021 | Nov 12, 2021 | −$108.00 | −$235.80 | -118.33% | $16.1M | $14.4M |
| Q2 2021 | Aug 16, 2021 | −$180.00 | −$180.00 | 0.00% | $14.1M | $12.0M |
| Q1 2021 | May 11, 2021 | −$180.00 | −$252.00 | -40.00% | $13.0M | $12.2M |
| Q4 2020 | Mar 11, 2021 | −$234.00 | −$180.00 | 23.08% | $14.5M | $15.8M |
| Q3 2020 | Nov 12, 2020 | −$324.00 | −$180.00 | 44.44% | $18.2M | $14.4M |
| Q2 2020 | Aug 12, 2020 | −$420.00 | −$396.00 | 5.71% | $14.9M | $21.1M |
| Q1 2020 | May 14, 2020 | −$552.00 | −$864.00 | -56.52% | $16.1M | $12.7M |

## Frequently Asked Questions

### When did DNA X (SONM) last report earnings?

DNA X last reported on Oct 31, 2025, covering fiscal Q3 2025.

### Did SONM beat earnings estimates?

No. DNA X reported EPS of −$4.83 for Q3 2025 against a $5.40 estimate — a 189.44% miss.

### How much revenue did SONM report last quarter?

DNA X reported $16.2M in revenue for Q3 2025, against a consensus estimate of $34.3M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).